Skip to Content
  • Review
  • Open Access

17 November 2026

19 Pages

The Role of Post-Translational Modifications of Metabolite-Related Proteins in Neuroblastoma: Mechanisms and Perspectives

,
,
,
,
,
,
and
1
Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2
Health Management Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430090, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.

Abstract

Neuroblastoma (NB) is one of the most common extracranial solid tumours in children, and significant therapeutic challenges remain for high-risk patients and those with recurrent or refractory disease. In recent years, the link between tumour metabolic reprogramming and epigenetic regulation has become an increasingly important factor in explaining the heterogeneity, invasiveness, metastasis, immune evasion, and treatment resistance observed in NB. Post-translational modifications (PTMs) not only determine protein stability, subcellular localisation, and signal transduction but also respond directly to changes in metabolite concentrations, translating the metabolic state of metabolites into alterations in chromatin and membrane signalling. This review focuses on post-translational modifications intimately associated with metabolic processes (lactylation, acetylation, glycosylation, and palmitoylation, among others), and their potential mechanisms of action, current evidence, and translational prospects in NB are examined. Research indicates that pathways such as MYCN, LDHA, and ACSS2 collectively shape the metabolic profile of NB; amongst these, lactic acid production and acetylation are already supported by relatively direct mechanistic evidence in NB, whilst glycosylation is closely associated with GD2-targeted therapy, risk stratification, and tumour immunity. Direct research into palmitoylation in NB remains relatively limited; however, its regulation of oncogenic pathways, membrane receptors, and lipid raft signalling suggests that it may be involved in NB progression. In this review, the literature on metabolism-related PTM dysregulation in neuroblastoma is systematically synthesised, highlighting its key regulatory role. Overall, metabolite-related PTMs offer new avenues for research into the molecular subtyping, prognostic assessment, and combination therapy of neuroblastoma.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.